Soluble ST2 in Paroxysmal Atrial Fibrillation: a New Biomarker that Predicts Recurrence?

Affiliations

Editorial

Ahmed AlTurki. Korean Circ J. 2018 Oct.

. 2018 Oct;48(10):930-932.

doi: 10.4070/kcj.2018.0183.

¹ Division of Cardiology, McGill University Health Center, Montreal, Quebec, Canada. ahmedalturkimd@gmail.com.

No abstract available

Conflict of interest statement

The author has no financial conflicts of interest.

Fibrosis Marker Soluble ST2 Predicts Atrial Fibrillation Recurrence after Cryoballoon Catheter Ablation of Nonvalvular Paroxysmal Atrial Fibrillation.
Okar S, Kaypakli O, Şahin DY, Koç M. Okar S, et al. Korean Circ J. 2018 Oct;48(10):920-929. doi: 10.4070/kcj.2018.0047. Korean Circ J. 2018. PMID: 30238709 Free PMC article.

1. AlTurki A, Marshall HJ, Proietti R. Targeting nonpulmonary vein triggers during atrial fibrillation ablation: is the game worth the candle? Curr Opin Cardiol. 2018;33:50–57. - PubMed
1. Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14:e275–e444. - PMC - PubMed
1. Balk EM, Garlitski AC, Alsheikh-Ali AA, Terasawa T, Chung M, Ip S. Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review. J Cardiovasc Electrophysiol. 2010;21:1208–1216. - PubMed
1. Tang RB, Yan XL, Dong JZ, et al. Predictors of recurrence after a repeat ablation procedure for paroxysmal atrial fibrillation: role of left atrial enlargement. Europace. 2014;16:1569–1574. - PubMed
1. AbouEzzeddine OF, McKie PM, Dunlay SM, et al. Suppression of tumorigenicity 2 in heart failure with preserved ejection fraction. J Am Heart Assoc. 2017;6:e004382. - PMC - PubMed